|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
Mcconnell Dowell Corporation (MDC.AX)
CHAIKIN MONEY FLOW
Trading: HOLD @ $0.4
Signal Strength: MEDIUM
Mcconnell Dowell Corporation (ASX:MDC) current price has highlighted recent buying pressure and the continuation of a bullish trading conditions. Currently, the CMF is 0.15. MDC.AX received a confirmed CMF crossover days on the May 8 2019. The bullish signal has been active for 0 day. During the quarter, the highest CMF value was 0.19 occurring on the May 8 2019.
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. Indicator can be applied to the short/medium term timeframe, but the best results are obtained with larger cyclical swings in-line with the trend direction. This accumulation / distribution oscillator can provide guidance on the money flow direction from the companies recent trading.
Developed by Marc Chaikin, Chaikin Money Flow measures the amount of Money Flow Volume over a specific period. Money Flow Volume forms the basis for the Accumulation Distribution Line. Instead of a cumulative total of Money Flow Volume, Chaikin Money Flow simply sums Money Flow Volume for a specific look-back period, typically 20 or 21 days. The resulting indicator fluctuates above/below the zero line just like an oscillator. Chartists weigh the balance of buying or selling pressure with the absolute level of Chaikin Money Flow. Chartists can also look for crosses above or below the zero line to identify changes on money flow.
Calculation: Chaikin Money Flow (20):
1) Money Flow Multiplier = [(Close - Low) - (High - Close)] / (High - Low);
2) Money Flow Volume = Money Flow Multiplier x Volume for the Period;
3) 20-period CMF = 20-period Sum of Money Flow Volume / 20 period Sum of Volume;
PROFILE: Mcconnell Dowell Corporation (MDC.AX)
Stock Exchange: ASX
Company: Mcconnell Dowell Corporation
Ticker Codes: | MDC.AX | ASX:MDC |
Medlab Clinical Limited, a medical research and development facility, engages in nutraceutical products and pharmaceutical research businesses in Australia. The company develops bio-therapeutics for chronic kidney diseases, pre-diabetes/obesity, depression, musculoskeletal muscle loss associated with ageing, and non-opioid pain management. It also provides nutraceuticals for anti-inflammatory, cardiovascular support, endocrine support, gastrointestinal support, immunological support, infants and toddlers, metabolic support, musculoskeletal support, neurological support, sports performance, urogenital support, and weight management, as well as for men, pregnancy, seniors, teenagers, and women support. The company has a strategic alliance with Heritage Brands Limited to develop and market its products for the pharmacy retail channel. Medlab Clinical Limited was founded in 2012 and is based in Alexandria, Australia.
|EVO Evolve Education||0.14||16.7||7,630,518||0.09||BULLISH|
|CUV Clinuvel Pharmaceuticals||31.19||8.3||136,460||0.3||BULLISH|
|LYC Lynas Corporation||2.43||7.5||23,854,412||0.08||BULLISH|
|PLS Pilbara Minerals||0.84||7.1||14,160,985||0.28||BULLISH|
|CWP Cedar Woods Properties||5.87||6.7||89,806||0.15||BULLISH|
|SWM Seven West Media||0.53||6||4,363,523||0.15||BULLISH|
|NHC New Hope||2.78||4.9||2,587,007||0.04||BULLISH|